{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:50:57Z","timestamp":1788565857720,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00246-017-1707-5","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T03:26:37Z","timestamp":1503545197000},"page":"1633-1638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Safety and Effectiveness of Flecainide in Children in the Current Era"],"prefix":"10.1007","volume":"38","author":[{"given":"Taylor","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Jeremiasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayan","family":"Sanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"1707_CR1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.1980.65","volume":"27","author":"P Somani","year":"1980","unstructured":"Somani P (1980) Antiarrhythmic effects of flecainide. Clin Pharmacol Ther 27:464\u2013470","journal-title":"Clin Pharmacol Ther"},{"key":"1707_CR2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9149(86)90022-6","volume":"58","author":"A Borgeat","year":"1986","unstructured":"Borgeat A, Goy JJ, Maendly R, Kaufmann U, Grbic M, Sigwart U (1986) Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 58:496\u2013498","journal-title":"Am J Cardiol"},{"key":"1707_CR3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/oxfordjournals.eurheartj.a062553","volume":"9","author":"HJ Crijns","year":"1988","unstructured":"Crijns HJ, van Wijk LM, van Gilst WH, Kingma JH, van Gelder IC, Lie KI (1988) Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate- comparison of two regimens. Eur Heart J 9:634\u2013638","journal-title":"Eur Heart J"},{"key":"1707_CR4","first-page":"710","volume":"101","author":"YM Cha","year":"1988","unstructured":"Cha YM, Zhang AP, Liu L, Sun JP, Huang W (1988) Flecainide acetate in dogs with ischemic tachyarrhythmia: an electrophysiologic study. Chin Med J 101:710\u2013714 (Engl)","journal-title":"Chin Med J"},{"key":"1707_CR5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","unstructured":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406\u2013412","journal-title":"N Engl J Med"},{"key":"1707_CR6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0735-1097(91)90586-X","volume":"18","author":"FA Fish","year":"1991","unstructured":"Fish FA, Gillette PC, Benson DW Jr (1991) Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 18:356\u2013365","journal-title":"J Am Coll Cardiol"},{"key":"1707_CR7","doi-asserted-by":"crossref","first-page":"95B","DOI":"10.1016\/0002-9149(84)90510-1","volume":"53","author":"MA Josephson","year":"1984","unstructured":"Josephson MA, Ikeda N, Singh BN (1984) Effects of flecainide on ventricular function: clinical and experimental correlations. Am J Cardiol 53:95B\u2013100B","journal-title":"Am J Cardiol"},{"key":"1707_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-8703(85)90413-2","volume":"109","author":"MA Josephson","year":"1985","unstructured":"Josephson MA, Kaul S, Hopkins J, Kvam D, Singh BN (1985) Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease. Am Heart J 109:41\u201345","journal-title":"Am Heart J"},{"key":"1707_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0735-1097(87)80096-7","volume":"9","author":"AA Paola de","year":"1987","unstructured":"de Paola AA, Horowitz LN, Morganroth J, Senior S, Spielman SR, Greenspan AM, Kay HR (1987) Influence of left ventricular dysfunction on flecainide therapy. J Am Coll Cardiol 9:163\u2013168","journal-title":"J Am Coll Cardiol"},{"key":"1707_CR10","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/0002-8703(92)90081-6","volume":"124","author":"JC Perry","year":"1992","unstructured":"Perry JC, Garson A Jr (1992) Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing. Am Heart J 124:1614\u20131621","journal-title":"Am Heart J"},{"key":"1707_CR11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/europace\/eut082","volume":"15","author":"J Brugada","year":"2013","unstructured":"Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, Abrams D, Bauersfeld U, Brugada R, Drago F, de Groot N, Happonen JM, Hebe J, Yen Ho S, Marijon E, Paul T, Pfammatter JP, Rosenthal E et al (2013) Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 15:1337\u20131382","journal-title":"Europace"},{"key":"1707_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1542-474X.2005.00077.x","volume":"10","author":"AJ Moss","year":"2005","unstructured":"Moss AJ, Windle JR, Hall WJ, Zareba W, Robinson JL, McNitt S, Severski P, Rosero S, Daubert JP, Qi M, Cieciorka M, Manalan AS (2005) Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol 10:59\u201366","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"1707_CR13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.hrthm.2014.12.009","volume":"12","author":"K Miyamoto","year":"2015","unstructured":"Miyamoto K, Aiba T, Kimura H, Hayashi H, Ohno S, Yasuoka C, Tanioka Y, Tsuchiya T, Yoshida Y, Hayashi H, Tsuboi I, Nakajima I, Ishibashi K, Okamura H, Noda T, Ishihara M, Anzai T, Yasuda S, Miyamoto Y, Kamakura S, Kusano K, Ogawa H, Horie M, Shimizu W (2015) Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations. Heart Rhythm 12:596\u2013603","journal-title":"Heart Rhythm"},{"key":"1707_CR14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hrthm.2015.09.027","volume":"13","author":"GJ Padfield","year":"2016","unstructured":"Padfield GJ, AlAhmari L, Lieve KV, AlAhmari T, Roston TM, Wilde AA, Krahn AD, Sanatani S (2016) Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of beta-blockade. Heart Rhythm 13:609\u2013613","journal-title":"Heart Rhythm"},{"key":"1707_CR15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","volume":"8","author":"TM Roston","year":"2015","unstructured":"Roston TM, Vinocur JM, Maginot KR, Mohammed S, Salerno JC, Etheridge SP, Cohen M, Hamilton RM, Pflaumer A, Kanter RJ, Potts JE, LaPage MJ, Collins KK, Gebauer RA, Temple JD, Batra AS, Erickson C, Miszczak-Knecht M, Kubus P, Bar-Cohen Y, Kantoch M, Thomas VC, Hessling G, Anderson C, Young ML, Cabrera Ortega M, Lau YR, Johnsrude CL, Fournier A, Kannankeril PJ, Sanatani S (2015) Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol 8:633\u2013642","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1707_CR16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.hrthm.2013.08.011","volume":"10","author":"A Khoury","year":"2013","unstructured":"Khoury A, Marai I, Suleiman M, Blich M, Lorber A, Gepstein L, Boulos M (2013) Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 10:1671\u20131675","journal-title":"Heart Rhythm"},{"key":"1707_CR17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1017\/S1047951111001272","volume":"22","author":"O Uzun","year":"2012","unstructured":"Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B (2012) Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young 22:372\u2013380","journal-title":"Cardiol Young"},{"key":"1707_CR18","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1111\/j.1747-0803.2011.00596.x","volume":"7","author":"OU Kilinc","year":"2012","unstructured":"Kilinc OU, Tuzcu V (2012) Successful elimination of significant arrhythmia burden with flecainide in an adolescent with long QT syndrome type 3. Congenit Heart Dis 7:E42\u2013E45","journal-title":"Congenit Heart Dis"},{"key":"1707_CR19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00246-014-0978-3","volume":"36","author":"BS Moffett","year":"2015","unstructured":"Moffett BS, Valdes SO, Lupo PJ, de la Uz C, Miyake C, Krenek M, Kim JJ (2015) Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol 36:146\u2013150","journal-title":"Pediatr Cardiol"},{"key":"1707_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0735-1097(89)90070-3","volume":"14","author":"JC Perry","year":"1989","unstructured":"Perry JC, McQuinn RL, Smith RT Jr, Gothing C, Fredell P, Garson A Jr (1989) Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. J Am Coll Cardiol 14:183\u2013192","journal-title":"J Am Coll Cardiol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-017-1707-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-017-1707-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-017-1707-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T06:38:52Z","timestamp":1510727932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-017-1707-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1707"],"URL":"https:\/\/doi.org\/10.1007\/s00246-017-1707-5","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}